"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","treatment_protocol_ch1","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","description.1","data_processing","platform_id","contact_name","contact_email","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","age:ch1","tissue:ch1"
"GSM6659348","Serum-Epithelial Ovarian Cancer-Sample1-Rep1","GSM6659348","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Serum sample, Epithelial Ovarian Cancer, Sample1","Homo sapiens","tissue: Serum","age: 54","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in epithelial ovarian cancer serum samples of sample 1","Serum sample, Epithelial Ovarian Cancer, Sample1, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659348/suppl/GSM6659348_SG12324209_257015610783_S001_miRNA_1100_Jul11_1_1.txt.gz","2570","54","Serum"
"GSM6659349","Serum-Epithelial Ovarian Cancer-Sample2-Rep1","GSM6659349","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Serum sample, Epithelial Ovarian Cancer, Sample2","Homo sapiens","tissue: Serum","age: 30","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in epithelial ovarian cancer serum samples of sample 2","Serum sample, Epithelial Ovarian Cancer, Sample2, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659349/suppl/GSM6659349_SG12324209_257015610783_S001_miRNA_1100_Jul11_1_2.txt.gz","2570","30","Serum"
"GSM6659350","Serum-Epithelial Ovarian Cancer-Sample3-Rep1","GSM6659350","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Serum sample, Epithelial Ovarian Cancer, Sample3","Homo sapiens","tissue: Serum","age: 54","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in epithelial ovarian cancer serum samples of sample 3","Serum sample, Epithelial Ovarian Cancer, Sample3, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659350/suppl/GSM6659350_SG12324209_257015610783_S001_miRNA_1100_Jul11_1_3.txt.gz","2570","54","Serum"
"GSM6659351","Serum-Epithelial Ovarian Cancer-Sample4-Rep1","GSM6659351","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Serum sample, Epithelial Ovarian Cancer, Sample4","Homo sapiens","tissue: Serum","age: 32","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in epithelial ovarian cancer serum samples of sample 4","Serum sample, Epithelial Ovarian Cancer, Sample4, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659351/suppl/GSM6659351_SG12324209_257015610783_S001_miRNA_1100_Jul11_1_4.txt.gz","2570","32","Serum"
"GSM6659352","Serum-Epithelial Ovarian Cancer-Sample5-Rep1","GSM6659352","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Serum sample, Epithelial Ovarian Cancer, Sample5","Homo sapiens","tissue: Serum","age: 46","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in epithelial ovarian cancer serum samples of sample 5","Serum sample, Epithelial Ovarian Cancer, Sample5, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659352/suppl/GSM6659352_SG12324209_257015610783_S001_miRNA_1100_Jul11_2_1.txt.gz","2570","46","Serum"
"GSM6659353","Serum-Epithelial Ovarian Cancer-Sample6-Rep1","GSM6659353","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Serum sample, Epithelial Ovarian Cancer, Sample6","Homo sapiens","tissue: Serum","age: 48","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in epithelial ovarian cancer serum samples of sample 6","Serum sample, Epithelial Ovarian Cancer, Sample6, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659353/suppl/GSM6659353_SG12324209_257015610783_S001_miRNA_1100_Jul11_2_2.txt.gz","2570","48","Serum"
"GSM6659354","Serum-Epithelial Ovarian Cancer-Sample7-Rep1","GSM6659354","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Serum sample, Epithelial Ovarian Cancer, Sample7","Homo sapiens","tissue: Serum","age: 50","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in epithelial ovarian cancer serum samples of sample 7","Serum sample, Epithelial Ovarian Cancer, Sample7, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659354/suppl/GSM6659354_SG12324209_257015610783_S001_miRNA_1100_Jul11_2_3.txt.gz","2570","50","Serum"
"GSM6659355","Serum-Epithelial Ovarian Cancer-Sample8-Rep1","GSM6659355","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Serum sample, Epithelial Ovarian Cancer, Sample8","Homo sapiens","tissue: Serum","age: 50","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in epithelial ovarian cancer serum samples of sample 8","Serum sample, Epithelial Ovarian Cancer, Sample8, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659355/suppl/GSM6659355_SG12324209_257015610783_S001_miRNA_1100_Jul11_2_4.txt.gz","2570","50","Serum"
"GSM6659356","Serum-Healthy Individual-Control1-Rep1","GSM6659356","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Serum sample, Healthy Individual, Control1","Homo sapiens","tissue: Serum","age: 39","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in healthy individual serum samples of control 1","Serum sample, Healthy Individual, Control1, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659356/suppl/GSM6659356_SG12324209_257015610782_S001_miRNA_1100_Jul11_1_1.txt.gz","2570","39","Serum"
"GSM6659357","Serum-Healthy Individual-Control2-Rep1","GSM6659357","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Serum sample, Healthy Individual, Control2","Homo sapiens","tissue: Serum","age: 30","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in healthy individual serum samples of control 2","Serum sample, Healthy Individual, Control2, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659357/suppl/GSM6659357_SG12324209_257015610782_S001_miRNA_1100_Jul11_1_2.txt.gz","2570","30","Serum"
"GSM6659358","Serum-Healthy Individual-Control3-Rep1","GSM6659358","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Serum sample, Healthy Individual, Control3","Homo sapiens","tissue: Serum","age: 43","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in healthy individual serum samples of control 3","Serum sample, Healthy Individual, Control3, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659358/suppl/GSM6659358_SG12324209_257015610782_S001_miRNA_1100_Jul11_1_3.txt.gz","2570","43","Serum"
"GSM6659359","Serum-Healthy Individual-Control4-Rep1","GSM6659359","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Serum sample, Healthy Individual, Control4","Homo sapiens","tissue: Serum","age: 43","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in healthy individual serum samples of control 4","Serum sample, Healthy Individual, Control4, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659359/suppl/GSM6659359_SG12324209_257015610782_S001_miRNA_1100_Jul11_1_4.txt.gz","2570","43","Serum"
"GSM6659360","Serum-Healthy Individual-Control5-Rep1","GSM6659360","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Serum sample, Healthy Individual, Control5","Homo sapiens","tissue: Serum","age: 44","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in healthy individual serum samples of control 5","Serum sample, Healthy Individual, Control5, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659360/suppl/GSM6659360_SG12324209_257015610782_S001_miRNA_1100_Jul11_2_1.txt.gz","2570","44","Serum"
"GSM6659361","Serum-Healthy Individual-Control6-Rep1","GSM6659361","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Serum sample, Healthy Individual, Control6","Homo sapiens","tissue: Serum","age: 65","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in healthy individual serum samples of control 6","Serum sample, Healthy Individual, Control6, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659361/suppl/GSM6659361_SG12324209_257015610782_S001_miRNA_1100_Jul11_2_2.txt.gz","2570","65","Serum"
"GSM6659362","Serum-Healthy Individual-Control7-Rep1","GSM6659362","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Serum sample, Healthy Individual, Control7","Homo sapiens","tissue: Serum","age: 51","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in healthy individual serum samples of control 7","Serum sample, Healthy Individual, Control7, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659362/suppl/GSM6659362_SG12324209_257015610782_S001_miRNA_1100_Jul11_2_3.txt.gz","2570","51","Serum"
"GSM6659363","Serum-Healthy Individual-Control8-Rep1","GSM6659363","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Serum sample, Healthy Individual, Control8","Homo sapiens","tissue: Serum","age: 35","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in healthy individual serum samples of control 8","Serum sample, Healthy Individual, Control8, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659363/suppl/GSM6659363_SG12324209_257015610782_S001_miRNA_1100_Jul11_2_4.txt.gz","2570","35","Serum"
"GSM6659364","Tissue-Simple Ovarian Cyst-Control1-Rep1","GSM6659364","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Tissue sample, Simple Ovarian Cyst, Control1","Homo sapiens","tissue: benign ovarian neoplastic tissue","age: 28","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in simple ovarian cyst tissue samples of control 1","Tissue sample, Simple Ovarian Cyst, Control1, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659364/suppl/GSM6659364_Z----SG12324209_257015610794_S001_miRNA_1100_Jul11_2_4.txt.gz","2570","28","benign ovarian neoplastic tissue"
"GSM6659365","Tissue-Simple Ovarian Cyst-Control2-Rep1","GSM6659365","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Tissue sample, Simple Ovarian Cyst, Control2","Homo sapiens","tissue: benign ovarian neoplastic tissue","age: 19","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in simple ovarian cyst tissue samples of control 2","Tissue sample, Simple Ovarian Cyst, Control2, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659365/suppl/GSM6659365_SG12324209_257015610796_S001_miRNA_1100_Jul11_1_1.txt.gz","2570","19","benign ovarian neoplastic tissue"
"GSM6659366","Tissue-Simple Ovarian Cyst-Control3-Rep1","GSM6659366","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Tissue sample, Simple Ovarian Cyst, Control3","Homo sapiens","tissue: benign ovarian neoplastic tissue","age: 17","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in simple ovarian cyst tissue samples of control 3","Tissue sample, Simple Ovarian Cyst, Control3, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659366/suppl/GSM6659366_SG12324209_257015610796_S001_miRNA_1100_Jul11_1_2.txt.gz","2570","17","benign ovarian neoplastic tissue"
"GSM6659367","Tissue-Simple Ovarian Cyst-Control4-Rep1","GSM6659367","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Tissue sample, Simple Ovarian Cyst, Control4","Homo sapiens","tissue: benign ovarian neoplastic tissue","age: 48","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in simple ovarian cyst tissue samples of control 4","Tissue sample, Simple Ovarian Cyst, Control4, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659367/suppl/GSM6659367_SG12324209_257015610796_S001_miRNA_1100_Jul11_1_3.txt.gz","2570","48","benign ovarian neoplastic tissue"
"GSM6659368","Tissue-Simple Ovarian Cyst-Control5-Rep1","GSM6659368","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Tissue sample, Simple Ovarian Cyst, Control5","Homo sapiens","tissue: benign ovarian neoplastic tissue","age: 32","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in simple ovarian cyst tissue samples of control 5","Tissue sample, Simple Ovarian Cyst, Control5, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659368/suppl/GSM6659368_SG12324209_257015610796_S001_miRNA_1100_Jul11_1_4.txt.gz","2570","32","benign ovarian neoplastic tissue"
"GSM6659369","Tissue-Simple Ovarian Cyst-Control6-Rep1","GSM6659369","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Tissue sample, Simple Ovarian Cyst, Control6","Homo sapiens","tissue: benign ovarian neoplastic tissue","age: 28","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in simple ovarian cyst tissue samples of control 6","Tissue sample, Simple Ovarian Cyst, Control6, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659369/suppl/GSM6659369_SG12324209_257015610796_S001_miRNA_1100_Jul11_2_1.txt.gz","2570","28","benign ovarian neoplastic tissue"
"GSM6659370","Tissue-Simple Ovarian Cyst-Control7-Rep1","GSM6659370","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Tissue sample, Simple Ovarian Cyst, Control7","Homo sapiens","tissue: benign ovarian neoplastic tissue","age: 34","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in simple ovarian cyst tissue samples of control 7","Tissue sample, Simple Ovarian Cyst, Control7, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659370/suppl/GSM6659370_SG12324209_257015610796_S001_miRNA_1100_Jul11_2_2.txt.gz","2570","34","benign ovarian neoplastic tissue"
"GSM6659371","Tissue-Simple Ovarian Cyst-Control8-Rep1","GSM6659371","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Tissue sample, Simple Ovarian Cyst, Control8","Homo sapiens","tissue: benign ovarian neoplastic tissue","age: 70","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in simple ovarian cyst tissue samples of control 8","Tissue sample, Simple Ovarian Cyst, Control8, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659371/suppl/GSM6659371_SG12324209_257015610796_S001_miRNA_1100_Jul11_2_3.txt.gz","2570","70","benign ovarian neoplastic tissue"
"GSM6659372","Tissue-Epithelial Ovarian Cancer-Sample1-Rep1","GSM6659372","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Tissue sample, Epithelial Ovarian Cancer, Sample1","Homo sapiens","tissue: EOC tissue","age: 30","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in epithelial ovarian cancer tissue samples of sample 1","Tissue sample, Epithelial Ovarian Cancer, Sample1, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659372/suppl/GSM6659372_SG12324209_257015610781_S001_miRNA_1100_Jul11_1_1.txt.gz","2570","30","EOC tissue"
"GSM6659373","Tissue-Epithelial Ovarian Cancer-Sample2-Rep1","GSM6659373","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Tissue sample, Epithelial Ovarian Cancer, Sample2","Homo sapiens","tissue: EOC tissue","age: 32","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in epithelial ovarian cancer tissue samples of sample 2","Tissue sample, Epithelial Ovarian Cancer, Sample2, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659373/suppl/GSM6659373_SG12324209_257015610781_S001_miRNA_1100_Jul11_1_2.txt.gz","2570","32","EOC tissue"
"GSM6659374","Tissue-Epithelial Ovarian Cancer-Sample3-Rep1","GSM6659374","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Tissue sample, Epithelial Ovarian Cancer, Sample3","Homo sapiens","tissue: EOC tissue","age: 54","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in epithelial ovarian cancer tissue samples of sample 3","Tissue sample, Epithelial Ovarian Cancer, Sample3, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659374/suppl/GSM6659374_SG12324209_257015610781_S001_miRNA_1100_Jul11_1_3.txt.gz","2570","54","EOC tissue"
"GSM6659375","Tissue-Epithelial Ovarian Cancer-Sample4-Rep1","GSM6659375","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Tissue sample, Epithelial Ovarian Cancer, Sample4","Homo sapiens","tissue: EOC tissue","age: 51","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in epithelial ovarian cancer tissue samples of sample 4","Tissue sample, Epithelial Ovarian Cancer, Sample4, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659375/suppl/GSM6659375_SG12324209_257015610781_S001_miRNA_1100_Jul11_1_4.txt.gz","2570","51","EOC tissue"
"GSM6659376","Tissue-Epithelial Ovarian Cancer-Sample5-Rep1","GSM6659376","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Tissue sample, Epithelial Ovarian Cancer, Sample5","Homo sapiens","tissue: EOC tissue","age: 46","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in epithelial ovarian cancer tissue samples of sample 5","Tissue sample, Epithelial Ovarian Cancer, Sample5, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659376/suppl/GSM6659376_SG12324209_257015610781_S001_miRNA_1100_Jul11_2_1.txt.gz","2570","46","EOC tissue"
"GSM6659377","Tissue-Epithelial Ovarian Cancer-Sample6-Rep1","GSM6659377","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Tissue sample, Epithelial Ovarian Cancer, Sample6","Homo sapiens","tissue: EOC tissue","age: 54","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in epithelial ovarian cancer tissue samples of sample 6","Tissue sample, Epithelial Ovarian Cancer, Sample6, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659377/suppl/GSM6659377_SG12324209_257015610781_S001_miRNA_1100_Jul11_2_2.txt.gz","2570","54","EOC tissue"
"GSM6659378","Tissue-Epithelial Ovarian Cancer-Sample7-Rep1","GSM6659378","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Tissue sample, Epithelial Ovarian Cancer, Sample7","Homo sapiens","tissue: EOC tissue","age: 50","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in epithelial ovarian cancer tissue samples of sample 7","Tissue sample, Epithelial Ovarian Cancer, Sample7, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659378/suppl/GSM6659378_SG12324209_257015610781_S001_miRNA_1100_Jul11_2_3.txt.gz","2570","50","EOC tissue"
"GSM6659379","Tissue-Epithelial Ovarian Cancer-Sample8-Rep1","GSM6659379","Public on Feb 24 2023","Oct 20 2022","Feb 25 2023","RNA","1","Tissue sample, Epithelial Ovarian Cancer, Sample8","Homo sapiens","tissue: EOC tissue","age: 50","Tissues are digested with liquid nitrogen before isolation of total RNA from tissue samples. Crushed samples (30-60 mg is preferred) are placed in 2 ml microcentrifuge tubes. Blood samples were immediately centrifuged at 3500xg for 15 min at 4°C. The supernatant serum was transferred to RNase-free tubes after centrifugation. Sample serum fractions were collected and stored at -80°C until laboratory workup.","About 500 mg of tissue samples were taken in sterile centrifuge tubes containing RNAlater Solution (Ambion, Life Technology, USA) stabilization and storage solution, stored at +4°C overnight and then stored at -80°C until studied. Peripheral blood was collected into EDTA tubes (5 ml).","total RNA","Total RNA was isolated with “QIAGEN RNeasy Plus Mini Kit” (QIAGEN, Germany) from tissue samples. The quantity of obtained total RNA was measured by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA), and the quality controls of them were done by Agilent RNA 6000 Nano Kit on Agilent Bioanalyzer 2100 system (Agilent Technologies, Santa Clara, CA, USA). After RNA extracts were evaluated with bioanalyzer, 8 samples with the highest quality (RNA Integrity Number (RIN) value >5) according to RIN were selected for microarray study. To extract total RNA including miRNA from serum (500ul input), “mirVana™ PARIS™ RNA and Native Protein Purification Kit” (Ambion, Life Technology, USA) was used following the manufacturer’s protocol. The purity and concentration of RNA samples of serum were determined by NanoDrop IMPLEN P-Class (Thermo Fisher Scientific, Waltham, MA, USA).","Cy3","For labelling, miRNA Labelling and Hybridization Kit (Agilent Technologies, Santa Clara, CA, USA) was used according to the manufacturer's instructions. Total RNAs extracted from both serum and tissue were labelled by cyanine 3-cytidine bisphosphate (pCp-Cy3).","9606","The labelled miRNAs were hybridized for 24 h on “Human miRNA Microarray Version 16” (Agilent Technologies, Santa Clara, CA, USA) slides. Labelled miRNAs were blocked by “10X GE Blocking agent” and were washed using Gene Expression Wash Buffer 1 and 2.","Slides were scanned immediately after washing on the Agilent SureScan Microarray Scanner (Model G2600D) using one color scan setting for 8x60k array slides (Scan Area 61x21.6 mm, Scan resolution 3um).","MiRNA expressions in epithelial ovarian cancer tissue samples of sample 8","Tissue sample, Epithelial Ovarian Cancer, Sample8, Replicate 1","The images provided after scanning were analyzed by “Agilent Feature Extraction (v.11.0.1.1)” software using default parameters (protocol miRNA_1100_Jul11 and Grid: 070156_D_F_20141006).","GPL20712","Tuba,,Gunel","gunel@istanbul.edu.tr","Istanbul University","Balabanaga mahallesi sehzadebasi cad.","Istanbul","Fatih","34134","Turkey","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM6659nnn/GSM6659379/suppl/GSM6659379_SG12324209_257015610781_S001_miRNA_1100_Jul11_2_4.txt.gz","2570","50","EOC tissue"
